MRI bone oedema is the strongest predictor of subsequent radiographic progression in early rheumatoid arthritis. Results from a 2-year randomised controlled trial (CIMESTRA)
Journal article published in 2009 by
M. L. Hetland,
Hetland Ml,
B. Ejbjerg,
K. Hørslev-Petersen,
S. Jacobsen,
A. Vestergaard,
A. G. Jurik,
Jurik Ag,
K. Stengaard-Pedersen,
P. Junker,
T. Lottenburger,
I. Hansen,
L. S. Andersen,
Andersen Ls,
U. Tarp 
and other authors.
and other authors.
